Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2019

16.07.2019 | ASO Author Reflections

ASO Author Reflections: Routine Radiologic Staging of Distant Metastases Must Be Recommended as a Binding Guideline After Diagnosis of Local Breast Cancer Recurrence

verfasst von: Uwe Güth, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Excerpt

The motivation for this study1 arose from a particular experience at the authors’ Breast Center network during the last year. In two cases of local recurrence (LR), the interdisciplinary tumor board recommended staging of distant metastases (DMs) followed by a surgical intervention (after the DMs were excluded). However, the surgeons responsible for the cases first performed the operation (mastectomy) and postponed staging of the DMs to the postoperative period. In both cases, however, DMs were found. Retrospectively, it must be questioned whether these mastectomies were justified. Strictly speaking, the preoperative informed consent was invalid because patient and doctor assumed a curative approach, which was not indicated. Both doctors responsible for this management were experienced breast surgeons. Why did they omit radiologic staging procedures before surgery? Obviously, they underestimated the actual risk of DMs, which is understandable because most of the international breast cancer guidelines omit the management of LR. The few guidelines that included recommendations regarding LR and advocated radiologic staging of DM once LR is diagnosed do not substantiate their opinion with citable references from the literature.2,3 Why? Some publications report data regarding a synchronous diagnosis of LR and DM, but this is not the main topic of these publications. Moreover, it is difficult and time-consuming to find the few relevant publications (PubMed lists nearly 3000 entries for the search for “breast cancer” and “local recurrence”). Until recently, no publications addressed this question explicitly but focused instead on the frequency of a concurrent diagnosis of LR and DM. Neuman et al.4 were the first to address the question. Their analysis, however, was restricted to patients with advanced stages of cancer at the initial diagnosis. The current study analyzed the metastatic patterns of patients with LR in an unselected cohort that included different types of previous surgery and all non-metastatic stages of cancer at diagnosis (n = 137). …
Literatur
4.
Zurück zum Zitat Neuman HB, Schumacher JR, Francescatti AB, et al. For the Alliance/American College of Surgeons Clinical Research Program Cancer Care Delivery Research Breast Cancer Surveillance Working Group. Risk of synchronous distant recurrence at time of locoregional recurrence in patients with stage II and III breast cancer (AFT-01). J Clin Oncol. 2018;36:975–80.CrossRefPubMedPubMedCentral Neuman HB, Schumacher JR, Francescatti AB, et al. For the Alliance/American College of Surgeons Clinical Research Program Cancer Care Delivery Research Breast Cancer Surveillance Working Group. Risk of synchronous distant recurrence at time of locoregional recurrence in patients with stage II and III breast cancer (AFT-01). J Clin Oncol. 2018;36:975–80.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Güth U, Vetter M, Huang DJ, et al. Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendations for staging imaging of node-negative, hormonal receptor negative disease. Ann Oncol. 2013;24:555–7.CrossRefPubMed Güth U, Vetter M, Huang DJ, et al. Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendations for staging imaging of node-negative, hormonal receptor negative disease. Ann Oncol. 2013;24:555–7.CrossRefPubMed
Metadaten
Titel
ASO Author Reflections: Routine Radiologic Staging of Distant Metastases Must Be Recommended as a Binding Guideline After Diagnosis of Local Breast Cancer Recurrence
verfasst von
Uwe Güth, MD
Publikationsdatum
16.07.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07610-6

Weitere Artikel der Ausgabe 11/2019

Annals of Surgical Oncology 11/2019 Zur Ausgabe

Health Services Research and Global Oncology

Requiem for Robotic Cancer Surgery? Not So Fast

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.